Advertisement Sanofi-aventis, Stanford University Bio-X ink research pact - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Sanofi-aventis, Stanford University Bio-X ink research pact

Sanofi-aventis has signed a multi-year research pact with Stanford University Bio-X to support, conduct and facilitates interdisciplinary, collaborative and research projects in the early phases of development.

As per the terms of the pact, both the parties are expected to fund up to five programs a year.

Sanofi-aventis may also host postdoctoral fellows at the company and Sanofi-aventis scientists may also be invited by Stanford faculty to be visiting scholars and to pursue research collaborations at Stanford.

Additionally, Sanofi-aventis will fund an annual research forum that will bring together Sanofi-aventis and Bio-X researchers to share knowledge and perspectives on relevant scientific matters and to discuss research projects funded through the collaboration.

Sanofi-aventis US senior vice president, chief science officer and chief medical officer Paul Chew said Bio-X researchers are exploring novel approaches needed in science today to accelerate the potential for scientific breakthroughs.